Home > Publications database > Reactivation of SOX17 Program as Immune-Evasion Mechanism in Early Colorectal Cancer Development. > print

001     293610
005     20241029102052.0
024 7 _ |a 10.1056/NEJMcibr2406393
|2 doi
024 7 _ |a pmid:39321383
|2 pmid
024 7 _ |a 0028-4793
|2 ISSN
024 7 _ |a 1533-4406
|2 ISSN
024 7 _ |a altmetric:168479452
|2 altmetric
037 _ _ |a DKFZ-2024-01926
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Ahadova, Aysel
|0 P:(DE-He78)07eef6d38a91f4642c810745c5bf5000
|b 0
|e First author
|u dkfz
245 _ _ |a Reactivation of SOX17 Program as Immune-Evasion Mechanism in Early Colorectal Cancer Development.
260 _ _ |a Waltham, Mass.
|c 2024
|b MMS
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1730193608_11638
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
500 _ _ |a #EA:D470#LA:D470# / 391(13), pp. 1250–1252
536 _ _ |a 314 - Immunologie und Krebs (POF4-314)
|0 G:(DE-HGF)POF4-314
|c POF4-314
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: inrepo02.dkfz.de
700 1 _ |a Kloor, Matthias
|0 P:(DE-He78)028ee60cca729028708496826f077b58
|b 1
|e Last author
|u dkfz
773 _ _ |a 10.1056/NEJMcibr2406393
|g p. NEJMcibr2406393
|0 PERI:(DE-600)1468837-2
|n 13
|p 1250–1252
|t The New England journal of medicine
|v 391
|y 2024
|x 0028-4793
909 C O |p VDB
|o oai:inrepo02.dkfz.de:293610
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 0
|6 P:(DE-He78)07eef6d38a91f4642c810745c5bf5000
910 1 _ |a Deutsches Krebsforschungszentrum
|0 I:(DE-588b)2036810-0
|k DKFZ
|b 1
|6 P:(DE-He78)028ee60cca729028708496826f077b58
913 1 _ |a DE-HGF
|b Gesundheit
|l Krebsforschung
|1 G:(DE-HGF)POF4-310
|0 G:(DE-HGF)POF4-314
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Immunologie und Krebs
|x 0
914 1 _ |y 2024
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2023-10-21
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2023-10-21
915 _ _ |a JCR
|0 StatID:(DE-HGF)0100
|2 StatID
|b NEW ENGL J MED : 2022
|d 2023-10-21
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0600
|2 StatID
|b Ebsco Academic Search
|d 2023-10-21
915 _ _ |a Peer Review
|0 StatID:(DE-HGF)0030
|2 StatID
|b ASC
|d 2023-10-21
915 _ _ |a IF >= 90
|0 StatID:(DE-HGF)9990
|2 StatID
|b NEW ENGL J MED : 2022
|d 2023-10-21
920 2 _ |0 I:(DE-He78)D470-20160331
|k D470
|l KKE Angewandte Tumorbiologie
|x 0
920 1 _ |0 I:(DE-He78)D470-20160331
|k D470
|l KKE Angewandte Tumorbiologie
|x 0
920 0 _ |0 I:(DE-He78)D470-20160331
|k D470
|l KKE Angewandte Tumorbiologie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-He78)D470-20160331
980 _ _ |a UNRESTRICTED

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21